How effective is glyceryl phenylbutyrate oral solution (Ravicti)?

Glycerol Phenylbutyrate Oral Liquid (Glycerol Phenylbutyrate Oral Liquid) is an effective drug for the treatment of urea cycle disorders (UCDs), and its therapeutic effect has been fully verified in clinical studies. Its active ingredient, glyceryl phenylbutyrate, is converted in the body to phenylacetate, which can combine with the amino acid glutamine to create a substance that can be cleared by the kidneys. This mechanism allows glycerol phenylbutyrin to play an important role in reducing nitrogen levels in the body, thereby reducing ammonia production.

Multiple studies have shown that glyceryl phenylbutyrin has significant effects in controlling blood ammonia levels. In a study of 88 adults with urea cycle disorders, Ravicti was compared with another treatment, sodium phenylbutyrate. The study showed that after four weeks of treatment, the average blood ammonia concentration in patients taking Ravicti was about 870 micromoles per liter, compared with 980 micromoles per liter in those taking sodium phenylbutyrate, suggesting Ravicti was at least as effective at lowering blood ammonia levels. This result shows that glycerol phenylbutyrin can effectively control ammonia metabolism in clinical applications and help patients maintain a healthy physiological state.

It is worth noting that Ravicti is a sustained-release drug, which means that its active ingredients can be continuously released over a longer period of time, thereby achieving round-the-clock blood ammonia level control. This characteristic makes the drug excellent at stably controlling ammonia concentrations. However, because of its sustained-release properties, Ravicti is not suitable for the treatment of acute hyperammonemia. In this case, patients need faster-acting drugs to quickly lower blood ammonia levels before they pose serious health risks.

In addition, pediatric patients have also shown good results during treatment withRavicti. Children who were treated with this drug from an early age also had their blood ammonia levels effectively controlled, further demonstrating the drug's safety and effectiveness in patients of different ages. This provides an effective long-term treatment option for patients with urea cycle disorders, especially those who cannot control ammonia levels through dietary management alone. Ravicti is particularly important.

Reference materials:https://www.ravicti.com/